Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period

Journal of Korean Medical Science

Volumn 24, Issue SUPPL.1, 2009, Pages

  Kim, Su Hyun ^a   Oh, Eun Jee ^b   Ghee, Jung Yeon ^b   Song, Hyun Kuk ^b   Han, Dong He ^b   Yoon, Hye Eun ^b   Choi, Bum Soon ^b   Yoon, Seung Kew ^b   Choi, Jong Young ^b   Moon, In Sung ^b   Kim, Dong Goo ^b   Yang, Chul Woo ^b  

^a Chung Ang University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Chronic; Graft rejection; Interleukin 10; Kidney failure; Kidney transplantation; Regulatory; T lymphocytes

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEPHROLOGY; REGULATORY T LYMPHOCYTE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHROLOGY; T-LYMPHOCYTES, REGULATORY;

EID: 62449294395     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S135     Document Type: Article

References (29)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
2. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 1295-302.
3. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285-94.
4. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005; 6: 338-44.
5. Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 2003; 81: 331-71.
6. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-6.
7. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210.
8. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641-6.
9. Sakaguchi S, Sakaguchi N. Regulatory T cells in immunologic selftolerance and autoimmune disease. Int Rev Immunol 2005; 24: 211-26.
10. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242-9.
11. Kim SH, Oh EJ, Kim MJ, Park YJ, Han K, Yang HJ, Kim JY, Choi BS, Yang CW, Kim YS, Bang BK. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients. Transplant Proc 2007; 39: 3057-60.
12. Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F, Cattaneo D, Perico N, Remuzzi G. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18: 1007-18.
13. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-8.
14. Schleifer SJ, Benton T, Keller SE, Dhaibar Y. Immune measures in alcohol-dependent persons with minor health abnormalities. Alcohol 2002; 26: 35-41.
15. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P. The liver: a special case in transplantation tolerance. Semin Liver Dis 2007; 27: 194-213.
16. Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM. Decreases in circulating CD4(+)CD-25(hi)FOXP3(+) cells and increases in intragraft FOXP3(+) cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2008; [Epub ahead of print].
17. Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 12: 277-84.
18. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789-96.
19. Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, van Meerwijk JP. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88-92.
20. Thornton AM, Shevach EM. Suppressor effector function of CD4+ CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-90.
21. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-96.
22. Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J, Contag CH, Negrin RS. Inhibition of CD4+CD25+ regulatory Tcell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108: 390-9.
23. Baan CC, van der Mast BJ, Klepper M, Mol WM, Peeters AM, Korevaar SS, Balk AH, Weimar W. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005; 80: 110-7.
24. Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J, Contag CH, Negrin RS. Inhibition of CD4+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108: 390-9.
25. Boschiero L, Nacchia F, Fior F, Cordiano C, Tridente G, Bellisola G. Specific alloantigen self-control by regulatory T cells in organ transplantation: a review. Transplant Proc 2007; 39: 2013-7.
26. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105: 4743-8.
27. Aramaki O, Inoue F, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Okumura K, Yagita H, Shirasugi N, Niimi M. Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen. Transplantation 2005; 79: 568-76.
28. van den Boogaardt DE, van Miert PP, de Vaal YJ, de Fijter JW, Claas FH, Roelen DL. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 2006; 82: 844-8.
29. Wood KJ, Luo S, Akl A. Regulatory T cells: potential in organ transplantation. Transplantation 2004; 77 (1 Suppl): S6-8.